Shanghai MicroPort MedBot (Group) Co., Ltd. (02252.HK)

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. The company is headquartered in Shanghai, Shanghai and currently employs 464 full-time employees. The company went IPO on 2021-11-02. The firm's business covers the fields of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The firm's products include Toumai LaparoscopicSurgical Robot, Toumai Single-port Laparoscopic Surgical Robot, DFVision Three Dimensions (3D) Electronic Laparoscope, SkyWalker Orthopedic Surgical Robot, Trans-bronchial Surgical Robot, R-ONE Vascular Interventional Robot, and iSR’obot Mona Lisa RoboticTransperineal Prostate Biopsy System. The firm conducts its businesses in domestic and overseas markets.